- Home
- LOVE vs AQST Comparison
LOVE vs AQST Comparison
Compare LOVE & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOVE
- AQST
- Stock Information
- Founded
- LOVE 1998
- AQST 2004
- Country
- LOVE United States
- AQST United States
- Employees
- LOVE N/A
- AQST N/A
- Industry
- LOVE Other Specialty Stores
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- LOVE Consumer Discretionary
- AQST Health Care
- Exchange
- LOVE Nasdaq
- AQST Nasdaq
- Market Cap
- LOVE 292.2M
- AQST 272.9M
- IPO Year
- LOVE 2018
- AQST 2018
- Fundamental
- Price
- LOVE $19.14
- AQST $2.71
- Analyst Decision
- LOVE Strong Buy
- AQST Strong Buy
- Analyst Count
- LOVE 5
- AQST 5
- Target Price
- LOVE $30.40
- AQST $11.40
- AVG Volume (30 Days)
- LOVE 361.1K
- AQST 1.7M
- Earning Date
- LOVE 06-12-2025
- AQST 05-12-2025
- Dividend Yield
- LOVE N/A
- AQST N/A
- EPS Growth
- LOVE N/A
- AQST N/A
- EPS
- LOVE 0.69
- AQST N/A
- Revenue
- LOVE $680,628,000.00
- AQST $54,228,000.00
- Revenue This Year
- LOVE $9.13
- AQST N/A
- Revenue Next Year
- LOVE $5.13
- AQST $40.62
- P/E Ratio
- LOVE $27.74
- AQST N/A
- Revenue Growth
- LOVE N/A
- AQST 5.29
- 52 Week Low
- LOVE $12.12
- AQST $2.12
- 52 Week High
- LOVE $39.49
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- LOVE 46.70
- AQST 54.01
- Support Level
- LOVE $18.29
- AQST $2.22
- Resistance Level
- LOVE $19.89
- AQST $2.79
- Average True Range (ATR)
- LOVE 0.75
- AQST 0.19
- MACD
- LOVE -0.15
- AQST 0.04
- Stochastic Oscillator
- LOVE 23.55
- AQST 75.64
About LOVE The Lovesac Company
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.